Jeffrey Alexander

Title: Innovations by Jeffrey Alexander in Genetic Engineering

Introduction

Jeffrey Alexander is a notable inventor based in Hayward, CA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of bacteriophages and transduction particles. His work focuses on creating innovative solutions for bacteria-related diseases.

Latest Patents

Jeffrey Alexander holds 1 patent for his invention titled "Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems." This invention relates to compositions and methods for producing genetically engineered bacteriophages, bacteriophage-like particles, and non-replicating transduction particles (NRTPs). These NRTPs contain non-native tail fibers that exhibit altered host specificity and reactivity. The invention also encompasses methods for utilizing these bacteriophages and NRTPs in developing novel diagnostics, therapeutics, and research reagents for bacteria-related diseases.

Career Highlights

Jeffrey Alexander is currently associated with Roche Molecular Systems, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the medical field by providing new tools for combating bacterial infections.

Collaborations

Some of his notable coworkers include Natacha Sorenson and Patrick Lin, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Jeffrey Alexander's innovative work in genetic engineering exemplifies the potential of scientific research to address critical health challenges. His contributions to the field are paving the way for new diagnostic and therapeutic solutions.